Content related to Clinical Trial Results: Patients with Leukemia Show High Remission Rates after Immunotherapy

Children’s Hospital Los Angeles study finds risk of detectable cancer cells decreased by 70% after one month of treatment in patients with ALL.

Scientists at Children’s Hospital Los Angeles develop newer CAR T therapy that promises to be more effective and less toxic for children with neuroblastoma.

Seattle Children’s, with participating members Children’s Hospital Los Angeles, Children’s National Health System and BC Children’s Hospital, has launched CureWorks, an international collaborative of